We are looking for an energetic and motivated individual to join our childhood cancer translational research team. We study a pediatric skeletal muscle solid tumor called rhabdomyosarcoma, and have a mandate by the NIH to inform new therapies for this difficult-to-treat disease. Focus is on understanding how corrupt coding and non-coding (“dark genome”) genes that are part of developmental signaling pathways (Notch, Hippo) support tumorigenesis and might reveal novel therapeutic vulnerabilities. Every project incorporates the evaluation of novel pharmacologic agents to shepherd to early phase clinical trials. We collaborate with investigators intramurally (Duke Pharmacology & Cancer Biology, Cell Biology, Biomedical Engineering), and extramurally nationally and internationally. Being independent and able to interface with multiple work groups is critical. We use biochemical, proteomic, cell biology, molecular biology, genomic, epigenomic, and mouse model approaches and collaborate with groups using artificial intelligence approaches and next-gen chemistry. We value teamwork, creativity, resilience and patient advocacy. A two-year commitment (or beyond) is preferred. See our lab’s website https://sites.duke.edu/corinnelinardiclab/.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees